Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

14 Feb 2023 09:23

RNS Number : 8730P
Liberum Capital Limited
14 February 2023
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Appreciate Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Appreciate Group plc

(d) Date dealing undertaken:

13th February 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 2p

 

 

Purchase

 

 

1,968

 

0.419

 

0.419

 

ORD 2p

 

 

Sale

 

 

2,168

 

0.419

 

0.419

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

14th February 2023

 

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGCGDDCBBDGXS
Date   Source Headline
1st Mar 20237:00 amRNSCancellation - Appreciate Group plc
28th Feb 20232:27 pmGNWADMISSION OF CONSIDERATION SHARES
28th Feb 20231:00 pmRNSForm 8.3 - APPRECIATE GROUP PLC
28th Feb 202310:05 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
28th Feb 20239:05 amGNWPaypoint Completes Acquisition of Appreciate Group
28th Feb 20239:00 amRNSScheme of Arrangement becomes effective
28th Feb 20237:30 amRNSSuspension - Appreciate Group PLC
27th Feb 202310:06 amRNSForm 8.3 -APPRECIATE GROUP PLC
27th Feb 20239:44 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
24th Feb 20232:08 pmRNSForm 8.3 - Paypoint Plc
24th Feb 20231:33 pmRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 202311:21 amRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 20239:56 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
24th Feb 20239:33 amRNSForm 8.5 (EPT/RI)
24th Feb 20239:21 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
23rd Feb 202312:34 pmRNSExercise of Options
23rd Feb 202312:11 pmRNSForm 8.3 - APPRECIATE GROUP PLC
23rd Feb 202312:04 pmRNSCourt Sanction of the Scheme of Arrangement
23rd Feb 202311:10 amRNSForm 8.3 -APPRECIATE GROUP PLC
23rd Feb 20239:37 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
23rd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
22nd Feb 20233:30 pmRNSForm 8.3 - APP LN
22nd Feb 20231:25 pmRNSForm 8.3 - APPRECIATE GROUP PLC
22nd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
21st Feb 20235:45 pmRNSPayPoint
21st Feb 20234:01 pmRNSForm 8.3 - PAY LN
21st Feb 20234:00 pmRNSForm 8.3 - APP LN
21st Feb 202312:20 pmRNSForm 8.3 - APPRECIATE GROUP PLC
21st Feb 20239:18 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
20th Feb 20233:30 pmRNSForm 8.3 - PAY LN
20th Feb 20233:30 pmRNSForm 8.3 - APP LN
20th Feb 20238:48 amRNSForm 8.5 (EPT/RI)
17th Feb 20233:30 pmRNSForm 8.3 - APP LN
17th Feb 20232:55 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 20232:36 pmRNSForm 8.3 - PAYP LN
16th Feb 20232:35 pmRNSForm 8.3 - APP LN
16th Feb 202312:28 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 202310:09 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
16th Feb 20238:41 amRNSForm 8.3 - Appreciate Group PLC
15th Feb 20232:23 pmRNSForm 8.3 - APPRECIATE GROUP PLC
15th Feb 202310:30 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
15th Feb 20238:34 amRNSForm 8.5 (EPT/RI)
15th Feb 20238:33 amRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20235:12 pmRNSHolding(s) in Company
14th Feb 20232:38 pmRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20232:30 pmRNSForm 8.3 - APP LN
14th Feb 20239:38 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
14th Feb 20239:23 amRNSForm 8.5 (EPT/RI)
13th Feb 202311:50 amRNSForm 8.3 - Appreciate Group Plc
13th Feb 202311:43 amRNSForm 8.3 - APPRECIATE GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.